fbpx

CHEMDIV’S LIBRARY
IN SIGNIFICANT RESEARCH

CHEMDIV’S LIBRARY
IN SIGNIFICANT RESEARCH


ChemDiv congratulates our colleagues from St. Jude Children’s Research Hospital who have published a new article regarding The von Hippel–Lindau (VHL) tumor and VHL ligand-binding assays.

They developed the first small-molecule-based high-affinity VHL fluorescent probe BODIPY FL VH032, with a Kd of 3.01 nM, for a time-resolved fluorescence resonance energy-transfer assay.

They reported that this new assay is sensitive, selective, resistant to assay interference, and capable of characterizing VHL ligands with a wide range of affinities. It is also suitable for VHL ligand identification and characterization with high-throughput screening.

We are especially proud that researchers used our custom-assembled alpha-helix library for pilot screening with the BODIPY FL VH032 (5)-mediated VHL TR-FRET Binding Assay.

Follow the link and read the full article⬇ https://pubs.acs.org/doi/abs/10.1021/acsomega.0c05221/


February 4, 2021 / Blog
X
Send a message
Request a call

    * Required fields

    By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      * Required fields

      By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      X